Performance of wrist-worn home sleep apnea testing (watch-PAT) among individuals with chronic insomnia: a comparative study with polysomnography - Report - MDSpire
Advertisement
Performance of wrist-worn home sleep apnea testing (watch-PAT) among individuals with chronic insomnia: a comparative study with polysomnography
Clinical Report: Evaluation of Wrist-Worn Home Sleep Apnea Monitoring
Overview
This study evaluates the diagnostic performance of the Watch-PAT 200 device for identifying moderate-to-severe obstructive sleep apnea (OSA) in patients with chronic insomnia. The findings indicate acceptable sensitivity and specificity, although caution is advised regarding sleep duration and staging parameters.
Background
Obstructive sleep apnea (OSA) affects a significant portion of the adult population and can lead to serious health complications if left untreated. Chronic insomnia is often comorbid with OSA, complicating diagnosis and treatment. Accurate screening and diagnosis are critical for effective management, particularly given the limitations of traditional polysomnography in certain patient populations.
Data Highlights
Measure
Value
Sensitivity
77.3% (95% CI 54.2–91.3%)
Specificity
100.0% (95% CI 81.5–100.0%)
AUC
0.92 (95% CI 0.80–0.98)
Diagnostic Agreement
82% (36 out of 44 subjects)
Overestimation of Total Sleep Time
19.9 min (limits of agreement −48.1 ~ 87.9 min)
Overestimation of REM Sleep Duration
37.2 min (limits of agreement −26.1 ~ 100.6 min)
Key Findings
The Watch-PAT 200 demonstrated a sensitivity of 77.3% for identifying moderate-to-severe OSA.
Specificity was found to be 100.0%, indicating no false positives in the study cohort.
The area under the receiver operating characteristic curve (AUC) was 0.92, suggesting high diagnostic accuracy.
Diagnostic agreement with polysomnography was achieved in 82% of participants.
The device overestimated total sleep time and REM sleep duration, necessitating cautious interpretation of these parameters.
Clinical Implications
The Watch-PAT 200 may serve as a viable option for diagnosing moderate-to-severe OSA in patients with chronic insomnia, offering a less invasive alternative to polysomnography. However, clinicians should be aware of the device's limitations in accurately measuring sleep duration and staging.
Conclusion
The wrist-worn Watch-PAT 200 device shows promise for diagnosing OSA in individuals with chronic insomnia, but careful interpretation of sleep metrics is essential.
